Literature DB >> 7639054

Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis.

K Dan1, S Gomi, K Inokuchi, K Ogata, T Yamada, I Ohki, S Hasegawa, T Nomura.   

Abstract

We studied the effects of interleukin-1 (IL-1) and tumor necrosis factor (TNF) on mouse megakaryocytopoiesis to evaluate the role of these cytokines in reactive thrombocytosis associated with inflammation. Injections of IL-1 or TNF to mice induced a significant increase in the megakaryocyte progenitor cell (CFU-Meg) count in the spleen. When IL-1 and TNF were injected simultaneously, the splenic CFU-Meg count was remarkably increased compared with mice injected with either IL-1 (p < 0.003) or TNF (p < 0.001) alone. On the other hand, neither IL-1 nor TNF showed any megakaryocyte-potentiating or -stimulating effects in vitro. In the sera obtained 4 h after administration of IL-1, TNF or both, high megakaryocyte potentiating activities were found. Furthermore, an extremely high level of IL-6 was detected in the serum after administration of both IL-1 and TNF. These results strongly suggest that IL-1 and TNF stimulate megakaryocytopoiesis indirectly via other cytokine(s) induced from accessory cells, and that increased levels of IL-1 and TNF play important roles in the development of reactive thrombocytosis caused by inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639054     DOI: 10.1159/000204114

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  9 in total

1.  Severe Thrombocytopenia Caused by Simvastatin in which Thrombocyte Recovery was Initiated after Severe Bacterial Infection.

Authors:  T Yamada; K Shinohara; K Katsuki
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 2.  Platelet Versus Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?

Authors:  Cédric Garcia; Baptiste Compagnon; Michaël Poëtte; Marie-Pierre Gratacap; François-Xavier Lapébie; Sophie Voisin; Vincent Minville; Bernard Payrastre; Fanny Vardon-Bounes; Agnès Ribes
Journal:  Cells       Date:  2022-04-30       Impact factor: 7.666

3.  Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis.

Authors:  I Ertenli; I C Haznedaroğlu; S Kiraz; I Celik; M Calgüneri; S Kirazhi
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

4.  Changes in platelet count and mean platelet volume during infectious and inflammatory disease and their correlation with ESR and CRP.

Authors:  Soheila Zareifar; Mohammad Reza Farahmand Far; Fatemeh Golfeshan; Nader Cohan
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

Review 5.  Pathologic thrombopoiesis of rheumatoid arthritis.

Authors:  Ihsan Ertenli; Sedat Kiraz; M Akif Oztürk; Ibrahim c Haznedaroğlu; Ismail Celik; Meral Calgüneri
Journal:  Rheumatol Int       Date:  2003-02-11       Impact factor: 2.631

6.  Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.

Authors:  Jonathan S Bleeker; William J Hogan
Journal:  Thrombosis       Date:  2011-06-08

7.  Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients.

Authors:  Kenzie D MacIsaac; Richard Baumgartner; Jia Kang; Andrey Loboda; Charles Peterfy; Julie DiCarlo; Jonathan Riek; Chan Beals
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

8.  Dual role of IL-21 in megakaryopoiesis and platelet homeostasis.

Authors:  Salima Benbarche; Catherine Strassel; Catherine Angénieux; Léa Mallo; Monique Freund; Christian Gachet; François Lanza; Henri de la Salle
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

9.  Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study.

Authors:  Lenar Yessayan; Jerry Yee; Gary Zasuwa; Stan Frinak; Anatole Besarab
Journal:  BMC Nephrol       Date:  2014-07-19       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.